Literature DB >> 29410174

Mortality after Spontaneous Subarachnoid Hemorrhage: Causality and Validation of a Prediction Model.

Yasser B Abulhasan1, Najayeb Alabdulraheem2, Gabrielle Simoneau3, Mark R Angle4, Jeanne Teitelbaum4.   

Abstract

OBJECTIVE: To evaluate primary causes of death after spontaneous subarachnoid hemorrhage (SAH) and externally validate the HAIR score, a prognostication tool, in a single academic institution.
METHODS: We reviewed all patients with SAH admitted to our neuro-intensive care unit between 2010 and 2016. Univariate and multivariate logistic regressions were performed to identify predictors of in-hospital mortality. The HAIR score predictors were Hunt and Hess grade at treatment decision, age, intraventricular hemorrhage, and rebleeding within 24 hours. Validation of the HAIR score was characterized with the receiver operating curve, the area under the curve, and a calibration plot.
RESULTS: Among 434 patients with SAH, in-hospital mortality was 14.1%. Of the 61 mortalities, 54 (88.5%) had a neurologic cause of death or withdrawal of care and 7 (11.5%) had cardiac death. Median time from SAH to death was 6 days. The main causes of death were effect of the initial hemorrhage (26.2%), rebleeding (23%) and refractory cerebral edema (19.7%). Factors significantly associated with in-hospital mortality in the multivariate analysis were age, Hunt and Hess grade, and intracerebral hemorrhage. Maximum lumen size was also a significant risk factor after aneurysmal SAH. The HAIR score had a satisfactory discriminative ability, with an area under the curve of 0.89.
CONCLUSIONS: The in-hospital mortality is lower than in previous reports, attesting to the continuing improvement of our institutional SAH care. The major causes are the same as in previous reports. Despite a different therapeutic protocol, the HAIR score showed good discrimination and could be a useful tool for predicting mortality.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clinical prediction rule; Mortality; Prognosis; Risk factors; Subarachnoid hemorrhage

Mesh:

Year:  2018        PMID: 29410174     DOI: 10.1016/j.wneu.2018.01.160

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  5 in total

1.  Admission rate-pressure product as an early predictor for in-hospital mortality after aneurysmal subarachnoid hemorrhage.

Authors:  Jingwei Zhao; Shaolan Zhang; Jiawei Ma; Guangzhi Shi; Jianxin Zhou
Journal:  Neurosurg Rev       Date:  2022-04-29       Impact factor: 2.800

2.  Easily created prediction model using deep learning software (Prediction One, Sony Network Communications Inc.) for subarachnoid hemorrhage outcomes from small dataset at admission.

Authors:  Masahito Katsuki; Yukinari Kakizawa; Akihiro Nishikawa; Yasunaga Yamamoto; Toshiya Uchiyama
Journal:  Surg Neurol Int       Date:  2020-11-06

3.  Mortality among patients treated for aneurysmal subarachnoid hemorrhage in Eastern Denmark 2017-2019.

Authors:  Agnes T Stauning; Frank Eriksson; Goetz Benndorf; Anders V Holst; John Hauerberg; Trine Stavngaard; Lars Poulsgaard; Per Rochat; Vagn Eskesen; Peter Birkeland; Tiit Mathiesen; Tina N Munch
Journal:  Acta Neurochir (Wien)       Date:  2022-07-22       Impact factor: 2.816

4.  Easily Created Prediction Model Using Automated Artificial Intelligence Framework (Prediction One, Sony Network Communications Inc., Tokyo, Japan) for Subarachnoid Hemorrhage Outcomes Treated by Coiling and Delayed Cerebral Ischemia.

Authors:  Masahito Katsuki; Shin Kawamura; Akihito Koh
Journal:  Cureus       Date:  2021-06-16

5.  Clinical characteristics and factors relating to poor outcome in patients with aneurysmal subarachnoid hemorrhage in Vietnam: A multicenter prospective cohort study.

Authors:  Chinh Quoc Luong; Hung Manh Ngo; Hai Bui Hoang; Dung Thi Pham; Tuan Anh Nguyen; Tuan Anh Tran; Duong Ngoc Nguyen; Son Ngoc Do; My Ha Nguyen; Hung Dinh Vu; Hien Thi Thu Vuong; Ton Duy Mai; Anh Quang Nguyen; Kien Hoang Le; Phuong Viet Dao; Thong Huu Tran; Luu Dang Vu; Linh Quoc Nguyen; Trang Quynh Pham; He Van Dong; Hao The Nguyen; Chi Van Nguyen; Anh Dat Nguyen
Journal:  PLoS One       Date:  2021-08-13       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.